trump glp-1 pilot program Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices Novo Nordisk, Lilly strike deal
Description
A new federal initiative aims to lower GLP-1 medication costs for Medicare beneficiaries
Key milestones highlighted in this timeline: 1999 Orlistat (Xenical) The first long-term FDA-approved anti-obesity medication of the modern era
Citing its post-market evaluation that found no increased risk of suicidal ideation or behavior, the U.S
FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Recently, d
Kirstie Canene-Adams and Dr
